Squamous cell carcinoma of the bladder is rare, accounting for 2% to 5% of bladder cancers in the U.S., and is linked to chronic bladder irritation. Diagnosis involves cystoscopy, biopsy, and imaging ...
Personal cancer journey emphasizes the emotional and physical challenges faced by patients during diagnosis and treatment. Patient advocacy is crucial in navigating the healthcare system and making ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based ...
In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.
Tonsil cancer is the most common form of oropharyngeal (throat) cancer. But among all types of cancer, tonsil cancer is still relatively rare, affecting a little more than eight out of 100,000 people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback